Your browser doesn't support javascript.
loading
Sleep and sleep disorders in people with Parkinson's disease.
Iranzo, Alex; Cochen De Cock, Valerie; Fantini, María Livia; Pérez-Carbonell, Laura; Trotti, Lynn Marie.
Affiliation
  • Iranzo A; Sleep Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain; IDIBAPS, Universitat de Barcelona, Barcelona, Spain; CIBERNED, Universitat de Barcelona, Barcelona, Spain. Electronic address: airanzo@clinic.cat.
  • Cochen De Cock V; Sleep and Neurology Department, Beau Soleil Clinic, Montpellier, France; EuroMov Digital Health in Motion, University of Montpellier, IMT Mines Ales, Montpellier, France.
  • Fantini ML; Neurophysiology Unit, Neurology Department, Université Clermont Auvergne, CNRS, Institut Pascal, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
  • Pérez-Carbonell L; Sleep Disorders Centre, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK.
  • Trotti LM; Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA; Emory Sleep Center, Emory University School of Medicine, Atlanta, GA, USA.
Lancet Neurol ; 23(9): 925-937, 2024 Sep.
Article in En | MEDLINE | ID: mdl-38942041
ABSTRACT
Sleep disorders are common in people with Parkinson's disease. These disorders, which increase in frequency throughout the course of the neurodegenerative disease and impair quality of life, include insomnia, excessive daytime sleepiness, circadian disorders, obstructive sleep apnoea, restless legs syndrome, and rapid eye movement (REM) sleep behaviour disorder. The causes of these sleep disorders are complex and multifactorial, including the degeneration of the neural structures that modulate sleep, the detrimental effect of some medications on sleep, the parkinsonian symptoms that interfere with mobility and comfort in bed, and comorbidities that disrupt sleep quality and quantity. The clinical evaluation of sleep disorders include both subjective (eg, questionnaires or diaries) and objective (eg, actigraphy or video polysomnography) assessments. The management of patients with Parkinson's disease and a sleep disorder is challenging and should be individualised. Treatment can include education aiming at changes in behaviour (ie, sleep hygiene), cognitive behavioural therapy, continuous dopaminergic stimulation at night, and specific medications. REM sleep behaviour disorder can occur several years before the onset of parkinsonism, suggesting that the implementation of trials of neuroprotective therapies should focus on people with this sleep disorder.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Sleep Wake Disorders Limits: Humans Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Sleep Wake Disorders Limits: Humans Language: En Journal: Lancet Neurol Journal subject: NEUROLOGIA Year: 2024 Type: Article